Teva Pharmaceutical to Cut 14,000 Jobs - WSJ
Teva Crashes Following Purdue Pharma $10-$12 Billion Settlement Reports | Ctech
Israel's Teva Pharm to start paying US opioid settlement in 2023 -CEO - The Jerusalem Post
Teva Pharmaceutical's Stock Tumbles on Outlook - WSJ
Teva Pharmaceutical's Sales Slump 18% - WSJ
Teva Pharmaceutical's Stock Tumbles on Outlook - WSJ
Teva Pharmaceutical's U.S. Unit Indicted on Price-Fixing Charges - WSJ
Teva seeks CEO replacement as Shultz will retire in 2023: WSJ
Teva Pharmaceutical Names Richard Francis as CEO, President - WSJ
Teva's Benign Opioid Settlement Isn't in the Bag Yet - WSJ
Teva reaches $523 million deal to settle opioid lawsuit with New York | CNN Business
Teva Pharmaceutical's Stock Tumbles on Outlook - WSJ
Teva shares surge after announcing global opioid settlement
Teva Agrees to Settle Opioid Lawsuits for as Much as $4.25 Billion - WSJ
Teva Agrees to Settle Opioid Lawsuits for as Much as $4.25 Billion - WSJ
Federal data reveals extent of Teva's role in fueling US opioid crisis | The Times of Israel
Prosecutors Sue Teva's U.S. Business Over Charitable Donations - WSJ
Teva Found Liable for Fueling Opioid Addiction in New York - WSJ
Teva Pharmaceutical to Replace CEO Kare Schultz - WSJ
Teva Pharmaceuticals found liable in New York opioid trial - BBC News
TEVA Beats on Q1 Earnings and Sales, Keeps View, Stock Down
Why You Should Still Buy Teva (NYSE:TEVA) | Seeking Alpha
Teva Tries to Put an End to the Opioid Wars - WSJ
Teva Pharmaceutical's Stock Tumbles on Outlook - WSJ
